Interleukin (IL)‎ 17 expression in Iraqi bladder carcinoma patients

المؤلف

Musa, Hind Muzhir

المصدر

Iraqi Journal of Biotechnology

العدد

المجلد 16، العدد 3 (30 سبتمبر/أيلول 2017)، ص ص. 94-97، 4ص.

الناشر

جامعة بغداد معهد الهندسة الوراثية و التقنيات الإحيائية للدراسات العليا

تاريخ النشر

2017-09-30

دولة النشر

العراق

عدد الصفحات

4

التخصصات الرئيسية

الأحياء

الملخص EN

Intcrlcukin (IL- 17) is pro inflammatory cytokincs produccd by CD4+ T-helpcrl7 (Thl7)ccll .It has a vital cffcct on cells of the immunc systcm playing crucial rôles in pathogcncsis of immunc-mcdiatcd discascs, likc-canccrs.

The eurrent study was designed to detcct the protein expression of IL-17 in Iraqi bladder carcinoma patients, and its corrélation with clinical grades.

Tissuc samplcs were collccted from 45 patients with bladder carcinoma.

The immunoexpression of IL-17 was dctcctcd by using IL-17 monoclonal antibody.

The results of Immunohistochcmical (IHC) studying showed that tissucs with positive (IL-17) expression were low in bladder cancer patients practically in low grades with signifieant différence, it is concludcd that IL-17 expression can bc used as indicators for procession in bladder cancer.

نمط استشهاد جمعية علماء النفس الأمريكية (APA)

Musa, Hind Muzhir. 2017. Interleukin (IL) 17 expression in Iraqi bladder carcinoma patients. Iraqi Journal of Biotechnology،Vol. 16, no. 3, pp.94-97.
https://search.emarefa.net/detail/BIM-811018

نمط استشهاد الجمعية الأمريكية للغات الحديثة (MLA)

Musa, Hind Muzhir. Interleukin (IL) 17 expression in Iraqi bladder carcinoma patients. Iraqi Journal of Biotechnology Vol. 16, no. 3 (2017), pp.94-97.
https://search.emarefa.net/detail/BIM-811018

نمط استشهاد الجمعية الطبية الأمريكية (AMA)

Musa, Hind Muzhir. Interleukin (IL) 17 expression in Iraqi bladder carcinoma patients. Iraqi Journal of Biotechnology. 2017. Vol. 16, no. 3, pp.94-97.
https://search.emarefa.net/detail/BIM-811018

نوع البيانات

مقالات

لغة النص

الإنجليزية

الملاحظات

Includes bibliographical references : p. 97

رقم السجل

BIM-811018